Varex Imaging Corp

Insider Trading Arrangements

During the fiscal quarter ended January 3, 2025, none of our directors or officers informed us of the adoption, modification, or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as follows:

On December 20, 2024, Sunny Sanyal, our CEO, President and a member of the Board of Directors, adopted a Rule 10b5-1 trading arrangement (the "December Plan") providing for: (i) the sale of shares of Company common stock currently owned by Mr. Sanyal in an amount not to exceed $100,000 in the aggregate during the term of the December Plan, with the aggregate number of shares to be sold during the term of the December Plan not to exceed 10,595 shares; and (ii) the exercise, subject to pricing triggers, of up to 592,450 stock options(1) (which includes shares to be withheld by the Company in payment of the exercise price and applicable taxes), that have vested or may vest to Mr. Sanyal pursuant to previous awards. Mr. Sanyal presently does not intend to sell the net shares he acquires pursuant to exercise of these options. The December Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Mr. Sanyal will continue to be subject to the Company's stock ownership guidelines. Sales contemplated by the December Plan will not reduce his ownership of Company common stock below the level required by the guidelines. Except as described herein below, the first date shares are permitted to be sold under the December Plan is March 20, 2025, and subsequent sales may occur until the expiration date, which is February 13, 2026, or earlier if all transactions under the December Plan are completed or it is otherwise earlier terminated. On March 5, 2024, Mr. Sanyal adopted a 10b5-1 Plan (the “March Plan”). The March Plan expires by its terms on March 7, 2025. If Mr. Sanyal were to amend, modify, or terminate the March Plan, rather than allow it to expire by its terms on March 7, 2025, trading under the Sanyal December 2024 Plan would not commence until a new cooling-off as required by Rule 10b5-1 was satisfied.

On December 20, 2024, Kimberley Honeysett, our Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement (the "2024 Plan") providing for: (i) the sale of 4,007 shares to be received upon vesting of restricted stock units scheduled to vest in February 2025; and (ii) the exercise, subject to pricing triggers, of up to 73,395 stock options, that have vested or may vest to Ms. Honeysett pursuant to previous awards and the related sale of the net shares acquired upon exercise, after withholding by the Company of shares in payment of the exercise price and applicable taxes. The 2024 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Except as described herein below, the first date that shares are permitted to be sold under the 2024 Plan is March 20, 2025, and subsequent sales may occur until the expiration date of the 2024 Plan, which is February 13, 2026, or earlier if all transactions under the 2024 Plan are completed or it is otherwise earlier terminated. On December 15, 2023, Ms. Honeysett adopted a 10b5-1 Plan (the “2023 Plan”). The 2023 Plan expires by its terms on February 14, 2025. If Ms. Honeysett were to amend, modify or terminate the 2024 Plan, rather than allow it to expire by its terms on February 15, 2025, trading under the 2024 Plan would not commence until a new cooling-off period as required of Rule 10b5-1 was satisfied.

(1) Includes 531,693 stock options that are also covered under the March Plan